Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 71.30
-2.20 (-2.99%)
Jul 30, 2026, 12:54 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 3.36 billion as of July 29, 2026. Its market cap has increased by 103.60% in one year.
Market Cap
3.36B
Enterprise Value
3.79B
Revenue
593.46M
Ranking
n/a
PE Ratio
530.08
Stock Price
71.30
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 3.36B, an increase of 338.11%. That is a compound annual growth rate of 7.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.36B | 137.10% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.49B |
| Panion & Bf Biotech | 5.12B |
| Easywell Biomedicals | 4.41B |
| LIWANLI Innovation | 4.08B |
| Orient EuroPharma | 4.08B |
| Yoda Pharmaceuticals | 3.04B |
| Maywufa Company | 2.74B |
| Allied Biotech | 2.32B |